Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Modigliani

Showing results (171-180 of 176) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 176 results.
European Journal of Human Genetics : EJHG|January 10, 2002
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel diseaseH Zouali, M Chamaillard, S Lesage, et al.
European Journal of Human Genetics : EJHG|March 14, 2003
Clustering of Crohn's disease within affected sibshipsJean-Pierre Hugot, Jean-Pierre Cézard, Jean-Frédéric Colombel, et al.
Gut|December 13, 2002
CARD4/NOD1 is not involved in inflammatory bowel diseaseH Zouali, S Lesage, F Merlin, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1996
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)C Florent, A Cortot, P Quandale, et al.
Nature|June 1, 2001
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseJ P Hugot, M Chamaillard, H Zouali, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
Pageof 18

Showing results (171-180 of 176) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 176 results.
European Journal of Human Genetics : EJHG|January 10, 2002
Genetic refinement and physical mapping of a chromosome 16q candidate region for inflammatory bowel diseaseH Zouali, M Chamaillard, S Lesage, et al.
European Journal of Human Genetics : EJHG|March 14, 2003
Clustering of Crohn's disease within affected sibshipsJean-Pierre Hugot, Jean-Pierre Cézard, Jean-Frédéric Colombel, et al.
Gut|December 13, 2002
CARD4/NOD1 is not involved in inflammatory bowel diseaseH Zouali, S Lesage, F Merlin, et al.
European Journal of Gastroenterology & Hepatology|March 1, 1996
Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID)C Florent, A Cortot, P Quandale, et al.
Nature|June 1, 2001
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's diseaseJ P Hugot, M Chamaillard, H Zouali, et al.
International Journal of Colorectal Disease|April 25, 2001
Use of anti-tumour necrosis factor agents in inflammatory bowel disease. European guidelines for 2001-2003S Schreiber, M Campieri, J F Colombel, et al.
Pageof 18